← Back to Search

Endoluminal Vascular Device

1 for Abdominal Aortic Aneurysm (l Trial)

N/A
Waitlist Available
Led By Edward B Diethrich, M.D.
Research Sponsored by Arizona Heart Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at implant, time of discharge, and 1, 6, and 12 months.
Awards & highlights

l Trial Summary

The purpose of the study is to evaluate the TALENT endoluminal stent-graft system in patients with abdominal aortic aneurysms. The TALENT endoluminal stent-graft system is a flexible, implantable endoluminal vascular device preloaded in a placement system that is used to exclude abdominal aortic aneurysms.

Eligible Conditions
  • Abdominal Aortic Aneurysm

l Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at implant, time of discharge, and 1, 6, and 12 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at implant, time of discharge, and 1, 6, and 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine the proportion in whom successful implantation is achieved, as indicated by aneurysm exclusion and graft patency.
Secondary outcome measures
Determine the proportion of patients who experience adverse events.
Determine the proportion of patients who experience comorbidities and overall mortality rates.

l Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Arizona Heart InstituteLead Sponsor
7 Previous Clinical Trials
825 Total Patients Enrolled
Edward B Diethrich, M.D.Principal InvestigatorArizona Heart Institute
6 Previous Clinical Trials
695 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025